Slow-release formulation of zinc is safe for Alzheimer's disease patients, and effectively raises serum zinc levels, but does not benefit cognition.
Richard Robinson
Advertisement
Articles by Richard Robinson
Selegiline inhibits MAO-A in the brain of patients with Parkinson's Disease without elevating the risk of hypertensive crisis from dietary tyramine.
Study results presented at AAN 2011 show that an experimental oral drug reduces the loss in ambulatory function in boys with Duchenne muscular dystrophy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Inhaled Treprostinil Improves IPF Outcomes in Phase 3 TETON-1 Trial
2
Moving the Needle in Medicine: Mentorship, Medicine, and the Making of an Innovator, With Jim Januzzi, MD
3
What We Still Don't Know: Gaps, Phototherapy, and the Future of Pediatric Eczema Care
4
When and How to Escalate Pediatric Atopic Dermatitis Treatment
5